FDA Expects Faster Reviews, Fewer Approvals In Fiscal Years 2005, 2006
Executive Summary
FDA estimates that the Center for Drug Evaluation & Research will conduct 165 standard NDA reviews in both fiscal years 2005 and 2006
You may also be interested in...
FDA Projects Increased Submissions, Fewer Approvals In FY 2006, 2007
FDA predicts an increase in applications over the next two years will not translate into more approvals within the fiscal 2006 and 2007 timeframe
FDA Projects Increased Submissions, Fewer Approvals In FY 2006, 2007
FDA predicts an increase in applications over the next two years will not translate into more approvals within the fiscal 2006 and 2007 timeframe
FDA Expects Increasing Flow Of Adverse Event Reports
FDA expects the Center for Drug Evaluation & Research to receive 17% more adverse reaction reports in fiscal year 2006 than it received in FY 2004